RhoJ Oncology

University of California, Irvine

RhoJ Oncology is focused on developing a cancer therapy that simultaneously disrupts both the tumor itself and its microenvironment. They have discovered a pathway that when disrupted, results in disruption of multiple cellular responses in cancer cells, via a single small molecule. They have completed animal studies, including PDX models, which demonstrate efficacy and show the molecule is effecting the cancer in multiple ways. Their current team is made up of talented scientists and we are looking for an entrepreneurial lead to help us secure funding to enable further development of this program.